Zealand Pharma A/S (ZEAL) — Cash Flow Quality Index
Latest as of June 2025:
1.12x
Zealand Pharma A/S (ZEAL) has a Cash Flow Quality Index of 1.12x as of June 2025. Operating cash flow of Dkr8.52 Billion exceeds net income of Dkr7.57 Billion, indicating high earnings quality where cash backs reported profits. Explore ZEAL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.12x
Operating CF / Net Income
Operating Cash Flow
Dkr8.52 Billion
DKK
Net Income
Dkr7.57 Billion
DKK
Data as of
Jun 2025
Most recent filing
Zealand Pharma A/S Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Zealand Pharma A/S across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ZEAL cash flow conversion.
Annual Cash Flow Quality Index for Zealand Pharma A/S (2011–2025)
Year-by-year earnings quality comparison for Zealand Pharma A/S.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | Dkr6.53 Billion | Dkr6.46 Billion | ▲ +227.8% |
| 2018 | -0.79x | Dkr-460.40 Million | Dkr581.28 Million | ▼ -142.0% |
| 2012 | 1.88x | Dkr68.54 Million | Dkr36.37 Million | ▲ +1495.7% |
| 2011 | -0.14x | Dkr-1.81 Million | Dkr13.38 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.